We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Diabetes

Journal Scan / Research · October 18, 2020

SGLT-2 Inhibitors May Be Targeting Higher-Risk Patients With Diabetes

Journal of Diabetes and Its Complications


Additional Info

Journal of Diabetes and Its Complications
SGLT-2 Inhibitors May Be Targeting Higher Risk Patients With Diabetes Possibly Justifying Higher Cost: Single Center Repeated Cross-Sectional Analysis
J Diabetes Complicat 2020 Oct 07;[EPub Ahead of Print], LA Weinrauch, J Liu, AR Segal, J Woodward, JA D’Elia

Further Reading